Viewing a single comment thread. View all comments

CatumEntanglement t1_iycaabv wrote

Thank you, thank you, thank you. As someone on the research side of human neurodegenerative diseases, this drug is, as you say...a crock of shit.

As an aside, all patients classified with idopathic/sporadic AD (which are 95% of cases) showed no change in the CDRSB scoring. This drug is no better than a placebo IMO. A very expensive ($30k-50k) placebo that has to be infused into the CSF and causes brain bleeds in 17% of patients. The only true significant thing this drug does is give people brain bleeds.

10